University of Wisconsin, Madison: Substance-Related Disorders trials

The registry lists 14 Substance-Related Disorders studies with University of Wisconsin, Madison as lead sponsor. 3 are open to participants now and 7 have results posted.

Phase 1 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The ENHANCE Project ToolkitRecruitingNCT07649278Not applicable
• Calls and Coordination for Transitions of Care at Re-entryRecruitingNCT06794983Not applicable
• Adjunctive Effects of Psilocybin and a Formulation of BuprenorphineRecruitingNCT04161066Phase 1
• Smartphone Intervention for Overdose and COVID-19CompletedNCT05518461Not applicableResults posted
• Criminal Justice Coordinated Transitional CareCompletedNCT05376371Not applicableResults posted
• Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3CompletedNCT04268173Not applicableResults posted
• E-health Implementation (Iowa)CompletedNCT03954184Not applicableResults posted
• Data-driven Identification for Substance MisuseCompletedNCT03833804Not applicableResults posted
• Physician Coaching to Reduce Opioid-related HarmsCompletedNCT02433496Results posted
• Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)CompletedNCT01963234Not applicableResults posted
• Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use DisordersActive, not recruitingNCT06109571Not applicable
• Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use DisorderTerminatedNCT05322954Phase 1
• ART-CHESS: A Mobile Health Application to Support People Living With HIV and AddictionCompletedNCT03873129Not applicable
• Exercise and Treatment-as-usual in Substance Use Treatment OutcomesCompletedNCT02570360Not applicable